BioNxt Solutions Inc.
BNXTF
$0.25
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -121.91% | -66.16% | -8.34% | -31.98% | -17.86% |
| Total Depreciation and Amortization | 119.51% | -80.37% | -76.33% | -70.66% | -123.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 207.86% | 147.14% | -16.63% | 23.82% | 339.18% |
| Change in Net Operating Assets | 156.28% | 149.00% | -205.49% | 247.61% | -239.48% |
| Cash from Operations | 53.85% | -1.45% | -770.59% | -2.51% | -25.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -12.59% | -- | -- | -96.84% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.59% | -- | -- | -96.84% | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 251.70% | 391.59% | -- | -54.34% | -82.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | 4,053.70% | -370.36% |
| Cash from Financing | -67.94% | -34.33% | -- | -52.67% | 103.17% |
| Foreign Exchange rate Adjustments | -116.67% | 50.00% | -57.14% | -100.00% | 500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.04% | -769.79% | 300.42% | -241.53% | 199.18% |